aMino]Methyl]-2-[[[[(3R](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/ser-agalnac-R_15ea1186-083d-4088-8a72-af6bb15f891f.svg?v=1732815768)
Pay in 4 interest-free payments of $59.38 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
1-[[[(4-Aminophenyl)sulfonyl](2-Methylpropyl)aMino]Methyl]-2-[[[[(3R
92 / / Asenapine N-β-D-Glucuronide / Asenapine Glucuronide
making the control of this modification crucial for the development of effective biopharmaceuticals
Galβ(1-3)GalNAc-α-1-O-Threonine (blocked amino acid)
mimicking the inner N-glycan substructure released by endo-β-mannosidase activity
GP100080: MUC1(126-149)-Tn(130,131,144) Pack Size:1 mg 1-[[[(4-Aminophenyl)sulfonyl](2-Methylpropyl)aMino]Methyl]-2-[[[[(3RC119H188N32O47 2818. 95 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Gly149; UniProt position 126 149, aa length 24) from the tandem repeat (TR) region of the MUC1 protein. The fragment contains tumor associated carbohydrate antigen (TACA), Tn antigen, O glycosylation ( GalNAc) at Ser130, Thr131 and Thr144. The C terminus is carboxylic acid. MUC1(126 149) Tn(130,131,144) Mucin1; Synthetic MUC 1 (tri Tn) glycopeptide
US$ 34.95
US$ 44.95
US$ 7150.00
US$ 19.99
US$ 22.50
